RBC Capital analyst Ben Hendrix raised the firm’s price target on Universal Health to $189 from $183 but keeps a Sector Perform rating on the shares. The company posted a solid start to 2024 with results ahead of expectations on volume strength and favorable labor cost trends in both segments, the analyst tells investors in a research note. Consistent with peer commentary, Universal Health’s segments saw strong volume trends in January and February before easing in March due to calendar effects, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $183 from $181 at TD Cowen
- Universal Health price target raised to $189 from $181 at Barclays
- Universal Health reports Q1 adjusted EPS $3.70 vs. $2.34 last year
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 FIRST QUARTER FINANCIAL RESULTS
- Universal Health reports Q1 adjusted EPS $3.70, consensus $3.16
